Aditxt, Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Aditxt, Inc. stock issued during period, value, other for the quarter ending 2024-03-31 was $1.60M.
- Aditxt, Inc. stock issued during period, value, other for the quarter ending 2022-09-30 was $878.62K, a 91.32% decline year-over-year.
- Aditxt, Inc. stock issued during period, value, other for the quarter ending 2022-06-30 was $1.20M, a 263.13% increase year-over-year.
- Aditxt, Inc. stock issued during period, value, other for the quarter ending 2021-09-30 was $10.12M, a 18.68% increase year-over-year.
- Aditxt, Inc. stock issued during period, value, other for fiscal 2024 was $1.60M.
- Aditxt, Inc. stock issued during period, value, other for fiscal 2022 was $80.00K, a 99.69% decline from fiscal 2021.
- Aditxt, Inc. stock issued during period, value, other for fiscal 2021 was $26.12M, a 206.37% increase from fiscal 2020.
- Aditxt, Inc. stock issued during period, value, other for fiscal 2020 was $8.53M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2024-12-31 | $1.60M 10-K · filed 2026-03-31 | |
| 2024-03-31 | $1.60M 10-Q · filed 2025-11-18 | |
| 2022-12-31 | $80.00K 10-K · filed 2024-04-16 | |
| 2022-09-30 | $878.62K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $1.20M 10-Q · filed 2022-08-15 | |
| 2021-12-31 | $26.12M 10-K · filed 2023-04-17 | |
| 2021-09-30 | $10.12M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $331.50K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.11M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $8.53M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $8.53M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |